SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Brian Sullivan
Spekulatius
To: Bart Hoenes who wrote (53150)1/10/2014 3:25:16 PM
From: Jurgis Bekepuris2 Recommendations  Read Replies (2) of 78613
 
Obviously below the S&P return last year, which I had as 29% (you had as 32.4%).
29.6% is S&P index return, 32.4 is S&P return including (reinvested, I think) dividends.

I think personally I am worse at picking segments than I am at picking stocks, so I would not try to outperform by picking some kind of split between S&P, Dow, SmallCaps, etc. Especially, I don't think you can predict when biotech will outperform and when it will underperform.

I like Greenblatt's idea of equally weighted index ( RSP ) or value-weighted index ( PRF ). Both of them outperformed S&P last year. If I was to discontinue active stock picking, I would pretty surely pick one of these two funds, fire and forget. :)

Other people might have better luck picking segments though.

Good luck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News